Cell labeling: tracking, viability and function

Simple item page
dc.contributor.authorSmith, SVen_AU
dc.date.accessioned2010-11-11T03:31:14Zen_AU
dc.date.available2010-11-11T03:31:14Zen_AU
dc.date.issued2005-12-01en_AU
dc.date.statistics2005-12-01en_AU
dc.description.abstractThe rapid progress in research of cell therapy for Parkinson's and Alzheimer's disease, cardiology and cancer has raised considerable excitement and controversy in recent times. In countries such as the UK, Sweden, Singapore, Korea, Japan and Australia, public dicussion has helped to clarify the regulatory framework for their stem cell research. Unfortunately the controversy continues in the US and is expected to significantly impact on the commercialization of much of this technology. © 2005, Edizioni Minerva Medicaen_AU
dc.identifier.citationSmith, S. V. (2005). Cell labeling: tracking, viability and function. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 49(4), 301-303.en_AU
dc.identifier.govdoc3047en_AU
dc.identifier.issn1824-4661en_AU
dc.identifier.issue4en_AU
dc.identifier.journaltitleQuarterly Journal of Nuclear Medicine and Molecular Imagingen_AU
dc.identifier.pagination301-303en_AU
dc.identifier.urihttp://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2005N04A0301en_AU
dc.identifier.urihttp://apo.ansto.gov.au/dspace/handle/10238/2847en_AU
dc.identifier.volume49en_AU
dc.language.isoenen_AU
dc.publisherEdizioni Minerva Medicaen_AU
dc.subjectStem cellsen_AU
dc.subjectNeoplasmsen_AU
dc.subjectRegulationsen_AU
dc.subjectDiseasesen_AU
dc.subjectTherapyen_AU
dc.subjectCommercializationen_AU
dc.titleCell labeling: tracking, viability and functionen_AU
dc.typeJournal Articleen_AU
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles